Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

370 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to verify the discriminatory value of previously identified salivary transcriptome and proteome markers for oral squamous cell cancer in an intended use population of patients with oral lesions suspicious for cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

NCT00899704

Head and Neck Cancer

WITHDRAWN

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity

NCT05791149

Oral Squamous Cell Carcinoma Maxillo-facial Surgery Biomarkers +3 more

UNKNOWN NA

Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma

NCT05821179

Oral Squamous Cell Carcinoma

COMPLETED

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

NCT00899340

Head and Neck Cancer

COMPLETED

Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

NCT05049408

Oral Squamous Cell Carcinoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Saliva samples are collected from patients before clinically driven oral biopsy for lesions suspicious for cancer. Specimens are processed by laboratory personnel blinded to the tissue diagnosis. Six pre-specified mRNA markers (IL1b, IL8, SAT, DUSP1, OAZ1 and S100P) are measured by polymerase chain reaction. Markers are compared in cancer and control by raw Ct values as well as by delta Ct after adjustment for housekeeping gens. Appropriate housekeeping genes are identified in a random subset of cancer and control patients and then verified in the remaining subjects. Predictive models are generated by a pre-specified method and robustness evaluated by bootstrap analysis. The model is then further validated in a second cohort. Three pre-specified protein markers (IL8, IL1B, and M2BP) are a secondary endpoint and will also be compared in cancer and control patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Squamous Cell Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oral lesions

oral lesions suspicious for squamous cell carcinoma with saliva collection prior to clinically driven oral biopsy

saliva collection prior to clinically driven oral biopsy

Intervention Type OTHER

cell free saliva to be used to measure mRNA and proteins by PCR and ELISA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

saliva collection prior to clinically driven oral biopsy

cell free saliva to be used to measure mRNA and proteins by PCR and ELISA

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients scheduled for biopsy of an oral lesion suspicious for squamous cell cancer

Exclusion Criteria

* Patients with known prior oral malignancy in last 2 years or other cancer in last 5 years other than non melanoma skin cancer or with immune deficiency

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No